CIM
RARE icon

CIM Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

CIM Investment Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,370
Closed -$214K – 312
2021
Q3 		$214K Hold
2,370
– – 0.07% 272
2021
Q2 		$226K Hold
2,370
– – 0.07% 269
2021
Q1 		$270K Buy
2,370
+853
+56% +$116K 0.09% 225
2020
Q4 		$210K Buy
+1,517
New +$180K 0.07% 268
2020
Q1 		– Sell
-4,780
Closed -$204K – 227
2019
Q4 		$204K Buy
+4,780
New +$197K 0.08% 209

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return